Virtu Financial’s Voyager Therapeutics VYGR Stock Holding History

Virtu Financial’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$299K	Buy	+77,478	New	+$305K	0.01%	815
2025 Q4	–	Sell	-19,937	Closed	-$93K	–	2294
2025 Q3	$93K	Buy	+19,937	New	+$72.1K	0.01%	1055
2025 Q1	–	Sell	-17,692	Closed	-$100K	–	2094
2024 Q4	$100K	Buy	+17,692	New	+$114K	0.01%	1019
2023 Q3	–	Sell	-27,855	Closed	-$319K	–	1953
2023 Q2	$319K	Buy	+27,855	New	+$288K	0.02%	589
2022 Q2	–	Sell	-18,443	Closed	-$141K	–	2124
2022 Q1	$141K	Buy	18,443 +8,141	+79%	+$36.3K	0.01%	898
2021 Q4	$28K	Buy	+10,302	New	+$35.1K	﹤0.01%	1464
2017 Q4	–	Sell	-23,171	Closed	-$477K	–	3078
2017 Q3	$477K	Buy	+23,171	New	+$261K	0.02%	967

Other funds holding VYGR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virtu Financial's VYGR Position: Q1 2026 in Review

Virtu Financial opened a new position in Voyager Therapeutics (VYGR) in Q1 2026: 77,478 shares worth $299K. The stake represents 0.01% of the portfolio and ranks #815 among its holdings. This is a return to the name: Virtu Financial previously reported a position in VYGR as recently as Q3 2025.

Virtu Financial first reported a position in VYGR in Q3 2017 and has held it in 7 quarters since. The position peaked at $477K in Q3 2017. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

Virtu Financial held 77,478 shares of Voyager Therapeutics worth $299K as of Q1 2026.
Voyager Therapeutics was a new Virtu Financial position in Q1 2026.
Voyager Therapeutics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #815 holding.
Virtu Financial first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 7 quarters since.
Virtu Financial's Voyager Therapeutics position peaked at $477K in Q3 2017.
135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.